A Risk Based Strategy for the Development & Validation of and Validation of Analytical Methods with a QbD Approach 2018

  • 05-06 Apr 2018
  • DoubleTree by Hilton Baltimore - BWI Airport, Linthicum, MD, United States

Description

A Risk Based Strategy for the Development & Validation of and Validation of Analytical Methods with a QbD Approach 2018 is a seminar that covers topics such as:

  • Quality Control and Quality Assurance in Analytical, R&D, QC, PD laboratories: General considerations, Quality Systems, QC procedures, QA oversight, Process Control Measure
  • An overview of global compliance issues, global harmonization initiatives, role of ICH, relevance of Validation activities & the Paradigm Shift
  • Measurement, Measurement Uncertainty, Measurement Resolution, Total Error, Bias
  • Perspectives of ICH, ISO Integration: ICH Q1 (Stability Studies), Q2 (Analytical Methods), Q3 (Impurities), Q7 (Pharma Process), Q9 (Risk Assessment), Q10 (Quality Systems), etc
  • A generic, science based outline of Methods Development & Validation [ab initio]
  • Analytical Measurement: Process Model & Risk Assessment (REMS) in Methods Dev
  • Validation Parameters, their generic definitions and their practical applications
  • Perspectives of QbD, PAT directives: online measurements /offline and the Paradigm Shift
  • Standardization/Qualification/Verification/Validation: the implicit continuum
  • Highlights of the guidelines derived from International Standards - ISO 17025, AOAC, WHO, GLP, GMP, EMEA, USP/EP/JP, etc
  • Some case histories and applications for improvement of Validation characteristics
  • The challenges in Methods Transfer, the premise of Co- Qualification
  • Methods Development and Optimization in HPLC, UV-VIS including assessment of Peak Purity, as examples of the most recent techniques widely used in analytical laboratories
  • Data integrity and statistical evaluation of analytical data: SQC, control charts etc
  • Preparation for Regulatory Inspections from FDA, EMA, WHO, ANVISA, etc
  • Phase Appropriate Validation & Regulatory submissions: IND/ ANDA/ NDA/ CMC

A Risk Based Strategy for the Development & Validation of and Validation of Analytical Methods with a QbD Approach 2018 brings together:

  • Managers
  • Scientists
  • Quality Assurance / Quality Control Staff
  • R&D Personnel
  • Validation Coordinators
  • Validation Managers
  • Regulatory/Compliance Managers
  • Production and Process Development Personnel
  • Technicians Study Directors(GLP)
  • Chemists
  • Pharmaceutical Development
  • Qualified Persons (EMEA)
  • CRO Managers
  • CRO Staff
  • Accredited Laboratories in general, any one engaged with Test Methods

Past Events

Important

Please, check "A Risk Based Strategy for the Development & Validation of and Validation of Analytical Methods with a QbD Approach" official website for possible changes, before making any traveling arrangements

Event Categories

Business: Quality assurance
Government & Global Issues: Law & Regulations
Health & Medicine: Medical device, Pharma

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions